Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novo Nordisk A/S
NVOCurrent price
111.97 USD
-0.19 USD (-0.17%)
Last closed
111.95 USD
Company
www.novonordisk.com
ISIN
US6701002056
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Capitalization
499 241 222 144 USD
Yield for 12 month
+10.77 %
1Y
3Y
5Y
10Y
15Y
NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Alle 1, Bagsvaerd, Denmark, 2880
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
142.92 USDP/E ratio
38.3356Dividend Yield
1.05 %Current Year
+33 872 190 418 USD
Last Year
+25 806 397 042 USD
Current Quarter
+9 925 649 506 USD
Last Quarter
+9 530 286 065 USD
Current Year
+28 656 338 897 USD
Last Year
+21 657 633 052 USD
Current Quarter
+8 427 322 691 USD
Last Quarter
+8 084 168 808 USD
Key Figures NVO
1 year
3 years
5 years
10 years
EBITDA
126 561 001 472 USD
Operating Margin TTM
PE Ratio
38.3356
Return On Assets TTM
22.8 %
PEG Ratio
1.7141
Return On Equity TTM
88.57 %
Wall Street Target Price
142.92 USD
Revenue TTM
258 002 993 152 USD
Book Value
25.24 USD
Revenue Per Share TTM
Dividend Share
9.9 USD
Quarterly Revenue Growth YOY
25.3 %
Dividend Yield
1.05 %
Gross Profit TTM
148 506 000 000 USD
Earnings per share
2.92 USD
Diluted Eps TTM
2.92 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
3.9 %
Profit Margin
34.84 %
Dividend Analytics NVO
Dividend growth over 5 years
62 %Continuous growth
4 yearsPayout Ratio 5 years average
19 %Dividend History NVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.45
Ex Dividend Date
16.08.2024
Forward Annual Dividend Yield
1.29 %
Last Split Factor
2:1
Payout Ratio
65.74 %
Last Split Date
20.09.2023
Dividend Date
26.08.2024
Stock Valuation NVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
38.3356
Forward PE
27.933
Enterprise Value Revenue
13.2404
Price Sales TTM
1.935
Enterprise Value EBITDA
25.5098
Price Book MRQ
30.4136
Financials NVO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVO
For 52 weeks
93.7 USD
147.59 USD
50 Day MA
124.2 USD
Shares Short Prior Month
5 804 410
200 Day MA
128.27 USD
Short Ratio
1.37
Shares Short
6 363 783
Short Percent
0.2 %
BeatStart